BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 21555802)

  • 1. Profile of HIV infected children from Delhi and their response to antiretroviral treatment.
    Gomber S; Kaushik JS; Chandra J; Anand R
    Indian Pediatr; 2011 Sep; 48(9):703-7. PubMed ID: 21555802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of HIV infected children from Delhi and their response to antiretroviral treatment.
    Gomber S; Kaushik JS; Chandra J; Anand R
    Indian Pediatr; 2011 Sep; 48(9):703-7. PubMed ID: 22102996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?
    Newell ML; Patel D; Goetghebuer T; Thorne C;
    J Infect Dis; 2006 Apr; 193(7):954-62. PubMed ID: 16518757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
    Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
    Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of malnutrition in survival of HIV infected children after initiation of antiretroviral treatment (ART).
    Taye B; Shiferaw S; Enquselassie F
    Ethiop Med J; 2010 Jan; 48(1):1-10. PubMed ID: 20607992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile of 516 children affected by HIV in a tertiary care centre in northern India: 14 years of experience.
    Singh S; Jat KR; Minz RW; Arora S; Suri D; Sehgal S
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):627-33. PubMed ID: 19217132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
    Song R; Jelagat J; Dzombo D; Mwalimu M; Mandaliya K; Shikely K; Essajee S
    Pediatrics; 2007 Oct; 120(4):e856-61. PubMed ID: 17846147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
    Resino S; Larrú B; Maria Bellón J; Resino R; de José MI; Navarro M; Léon JA; Ramos JT; Mellado MJ; Muñoz-Fernández MA
    BMC Infect Dis; 2006 Jul; 6():107. PubMed ID: 16834769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of anti-retroviral treatment in HIV-infected orphans and non-orphans at an ART centre in North India.
    Bhattacharya M; Saxena R
    Paediatr Int Child Health; 2012; 32(4):228-32. PubMed ID: 23164297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.
    Lihana RW; Lwembe RM; Bi X; Ochieng W; Panikulam A; Palakudy T; Musoke R; Owens M; Ishizaki A; Okoth FA; Songok EM; Ichimura H
    J Clin Virol; 2011 Oct; 52(2):123-8. PubMed ID: 21798798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children.
    Feucht UD; Kinzer M; Kruger M
    J Trop Pediatr; 2007 Dec; 53(6):398-402. PubMed ID: 17965099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral Service to HIV patients of low CD4 count in Seti Zonal Hospital.
    Paudel BN; Chaudhary SR; Sharma S; Dhungana GP; Paudel P
    JNMA J Nepal Med Assoc; 2009; 48(173):24-7. PubMed ID: 19529054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of vertically HIV-infected children in Europe.
    Thorne C; Gray L; Newell ML;
    Acta Paediatr; 2003; 92(2):246-50. PubMed ID: 12710655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scenario of HIV/AIDS patients in a government hospital of Nepal.
    Poudel BN; Dhungana GP
    J Nepal Health Res Counc; 2010 Oct; 8(2):103-6. PubMed ID: 21876573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of HIV-infected children with tuberculosis who are started on antiretroviral therapy in Malawi.
    Bong CN; Chen SC; Jong YJ; Tok TS; Hsu CF; Schouten EJ; Makombe SD; Yu JK; Harries AD
    Int J Tuberc Lung Dis; 2007 May; 11(5):534-8. PubMed ID: 17439677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of absolute lymphocyte count as a marker to assess the need to initiate antiretroviral therapy in HIV-infected children.
    Shah I; Parikh S
    J Postgrad Med; 2012; 58(3):176-9. PubMed ID: 23023348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.